A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

NCT03543410 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Episode
Bipolar 1 Depression

Interventions

DRUG: SEP-4199 200 mg
DRUG: SEP-4199 400 mg
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.